A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method

Overview of attention for article published in BMC Cancer, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs: 1 blog

twitter: 7 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 70 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Cancer Prevention Group’s Christmas reading list

Cancer Prevention Group, 13 Dec 2019

As the year draws to an end, we have been looking back and reflecting on the groups achievements in 2019. We decided that the…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.